Association between decreased pulmonary endothelial cell thrombomodulin and local fibrin deposition in pneumonia

被引:4
作者
Albertson, CM
Richter, KK
Kudryk, BJ
Fink, LM
Hauer-Jensen, M
机构
[1] Univ Arkansas Med Sci, Dept Pathol & Lab Med, Little Rock, AR 72205 USA
[2] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[3] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[4] New York Blood Ctr, New York, NY 10021 USA
关键词
bronchopneumonia; thrombomodulin; fibrin; immunohistochemistry;
D O I
10.1097/00001721-200112000-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombomodulin (TM) plays an important role in anticoagulation by forming a complex with thrombin, which subsequently activates protein C. TM is inactivated and downregulated by inflammatory cell mediators. This study examined whether bronchopneumonia is associated with changes in TM immunoreactivity, and whether a decrease in TM is accompanied by evidence of hypercoagulability, i.e. local deposition of fibrin. Double antibody staining for TM and fibrin was performed on lung tissue sections from patients who had died of pneumonia and from patients who had died rapidly, secondary to trauma. Inflammatory changes were assessed histologically and immunohistochemically using antibodies against interleukin-1 alpha, tumor necrosis factor-alpha, and myeloperoxidase. Areas with bronchopneumonia exhibited markedly decreased endothelial TM staining of alveolar walls and small vessels. These changes were associated with prominent fibrin immuno reactivity. Some areas exhibited mild to moderate inflammation with little fibrin deposition and variable amounts of TM in adjacent vessels. This study is the first to relate changes of TM immunoreactivity levels to fibrin deposition in a human disease process. These data may have implications for pulmonary pathophysiology in patients with bronchopneumonia. Blood Coagul Fibrinolysis 12:729-733 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:729 / 733
页数:5
相关论文
共 21 条
[1]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[2]   Elevated sevum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis [J].
Boehme, MWJ ;
Autschbach, F ;
Zuna, I ;
Scherbaum, WA ;
Stange, E ;
Raeth, U ;
Sieg, A ;
Stremmel, W .
GASTROENTEROLOGY, 1997, 113 (01) :107-117
[3]   TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS [J].
CONWAY, EM ;
ROSENBERG, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5588-5592
[4]   THE REGULATION OF NATURAL ANTICOAGULANT PATHWAYS [J].
ESMON, CT .
SCIENCE, 1987, 235 (4794) :1348-1352
[5]  
ESMON CT, 1982, J BIOL CHEM, V257, P7944
[6]  
ESMON NL, 1983, J BIOL CHEM, V258, P2238
[7]  
FULCHER CA, 1984, BLOOD, V63, P486
[8]   MECHANISMS OF ABNORMAL GAS-EXCHANGE IN PATIENTS WITH PNEUMONIA [J].
GEA, J ;
ROCA, J ;
TORRES, A ;
AGUSTI, AGN ;
WAGNER, PD ;
RODRIGUEZROISIN, R .
ANESTHESIOLOGY, 1991, 75 (05) :782-789
[9]   OXIDATION OF A SPECIFIC METHIONINE IN THROMBOMODULIN BY ACTIVATED NEUTROPHIL PRODUCTS BLOCKS COFACTOR ACTIVITY - A POTENTIAL RAPID MECHANISM FOR MODULATION OF COAGULATION [J].
GLASER, CB ;
MORSER, J ;
CLARKE, JH ;
BLASKO, E ;
MCLEAN, K ;
KUHN, I ;
CHANG, RJ ;
LIN, JH ;
VILANDER, L ;
ANDREWS, WH ;
LIGHT, DR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2565-2573
[10]  
ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618